Medtronic's Q2 2027 Earnings: What to Expect Medtronic will release its second-quarter earnings soon, and analysts anticipate a low single-digit profit dip. Barchart · 15h ago
Is Medtronic Stock Underperforming the Dow? While Medtronic has outperformed relative to the Dow over the past three months, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Sep 2
Medtronic’s Stars Are Aligning for a Price Recovery Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status. MarketBeat · Sep 1
Do Wall Street Analysts Like Medtronic Stock? Medtronic has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects. Barchart · Aug 4
Medtronic Earnings Preview: What to Expect : Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth. Barchart · Jul 23
Medtronic Bottoms, Healthy Rebound Ahead Medtronic is on track to reverse after a major market meltdown driven by fear. The upside potential is double-digit, not including the dividend. MarketBeat · Jun 4
Stocks Fall on Escalation of US-Iran Hostilities The S&P 500 Index ($SPX ) (SPY ) today is down -0.40%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.08%. June E-mini S&P futures (ESM26 ) are down -0.48%, and June E-mini Nasdaq futures... Barchart · Jun 3
Stocks Pressured as Middle East Flare-Ups Boost Crude Oil The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.60%. June E-mini S&P futures (ESM26 ) are down -0.50%, and June E-mini Nasdaq futures... Barchart · Jun 3
Medtronic Q4 Earnings Call Highlights Medtronic (NYSE:MDT) reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations. Chairman and C MarketBeat · Jun 3
Is Medtronic Stock Underperforming the Nasdaq? Medtronic has underperformed the Nasdaq Composite, and analysts remain somewhat optimistic about the stock’s outlook. Barchart · Jun 1
Jobs Data, Tech Earnings and Other Key Things to Watch this Week Markets face a big week focused almost entirely on labor market assessment as comprehensive employment data builds toward Friday's May jobs report at 8:30am that will provide crucial insights into whether the labor market is stabilizing or continuing to deteriorate. Barchart · May 31
3 Dividend Aristocrats Under $100 to Buy and Hold Forever These three Dividend Aristocrats under $100 offer steady payouts, reasonable payout ratios, and analyst-backed upside potential. Barchart · May 15
Medtronic Stock Outlook: Is Wall Street Bullish or Bearish? Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. Barchart · May 6
What You Need to Know Ahead of Medtronic's Earnings Release Medtronic is expected to release its fiscal fourth-quarter earnings soon, and analysts project a single-digit profit drop. Barchart · Apr 24
Barchart · Mar 16 How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks? Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects.
Barchart · Mar 3 Should You Buy MMED Stock After the MiniMed IPO? MiniMed, a spinoff of Medtronic, is expected to price its IPO on March 5.
Barchart · Feb 21 These 3 Dividend Aristocrats Look Ready to Rebound in 2026. Should You Buy Them Now? Three oversold Dividend Aristocrats near recent lows offering reliable income, strong analyst support, and significant upside potential.
MarketBeat · Feb 17 Medtronic’s “Textbook” Reversal: How High Can It Really Go in 2026? Medtronic's stock price reversal gained traction in late fiscal 2025, setting the market up for a 2026 rally, potentially hitting $125.
Barchart · Feb 17 Stocks Retreat on AI Anxiety The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.51%. March E-mini S&P futures (ESH26 ) are down -0.20%, and March E-mini Nasdaq futures...
Barchart · Feb 2 Are Wall Street Analysts Predicting Medtronic Stock Will Climb or Sink? Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
Barchart · Jan 22 What to Expect From Medtronic's Next Quarterly Earnings Report Medtronic is expected to announce its fiscal third-quarter earnings next month, and analysts project a single-digit profit drop.
Barchart · Jan 3 3 Best Dividend Aristocrats to Buy in 2026 These Dividend Aristocrats have strong earnings growth, solid yields, and Wall Street buy ratings stand out as smart income plays for 2026.
Benzinga · Dec 4, 2025 Medtronic Scores FDA Win As Hugo Surgical Robot Enters 230,000 Urology Procedure Market On Wednesday, the U.S. Food and Drug Administration (FDA) cleared Medtronic Plc’s (NYSE:MDT) Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures.
Barchart · Nov 28, 2025 How Is Medtronic's Stock Performance Compared to Other Medical Devices Stocks? Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.
MarketBeat · Nov 19, 2025 Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum Medtronic is on track to advance in 2026 and could rise by 20% to 30% before year-end. Analysts and institutions are accumulating in 2025.